Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Otix Global Inc.

Division of William Demant Holding AS

Latest From Otix Global Inc.

Rumblings of Change in the Hearing Markets: Sonova Buys Advanced Bionics

The hearing markets have followed a different evolutionary branch than the rest of the medical world, with a complicated infrastructure, and a schism between its two main product categories; the hearing aids sold through the audiology channel, and cochlear implants, surgical devices marketed to ENTs. This fragmentation has long kept the hearing markets from realizing their potential. The recent merger of Advanced Bionics with Sonova is a major step toward bridging the chasm in the hearing impairment industry, and perhaps in beginning to change its dynamics.
Business Strategies

MPM's Challenge: Investing the Largest Health Venture Fund

MPM has raised a $900 million fund. What's it going to spend it on in these troubled times, when valuations across all sectors of the life sciences industry are slipping? MPM plans to direct two-thirds of the fund to product and technology companies, and a third to applied platform firms. The fund will aim for an 80/20 between pharmaceuticals and devices. MPM is particularly keen to find quality-of-life investments for its portfolio. In the pharma sector, MPM may at times take a stripped-down approach to building companies, but it will also do some buy-outs and generally be prepared to invest more and support start-ups longer than VCs did historically.
BioPharmaceutical Medical Device

Hearing Aids: Innovators Must Change the Channel

Ten percentage of the population in industrialized companies could benefit from hearing aids, and since the market remains 80% unpenetrated, new hearing aid companies and their financial backers see an enormous opportunity. But the hearing industry presents unique challenges compared to other medical device markets; the poor performance of past devices keeps people from buying hearing aids, as does the lack of reimbursement. Profitability is difficult for manufacturers to achieve, because manufacturing of the custom devices doesn't benefit from economies of scale. Finally, small companies have a tough time getting past the gatekeepers of the hearing industry--audiologists who have entrenched relationships with dominant manufacturers. New companies are entering the market with widely different approaches, some based on technology, some based on changing distribution channels. For some, the new approaches have clearly failed; others are embarking on new strategies that have yet to play out.
Medical Device Leadership

Morgenthaler's Life Sciences Renewal

Morgenthaler Ventures, biotech, medical device, and communications/computer technology investors since the mid-'80s, backed away from the biotech group in 1993. But the investment pendulum has now swung away from IT and toward health care. So the firm is back into biotech investing, and is also picking up the pace in devices.
BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Medical Devices
  • Therapeutic Areas
  • Otolaryngology
  • Alias(es)
  • Sonic Innovations Inc.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • William Demant Holding AS
  • Senior Management
  • Samuel L Westover, Chmn., Pres. & CEO
    Michael Halloran, VP & CFO
    Jerry L DaBell, VP, R&D
  • Contact Info
  • Otix Global Inc.
    Phone: (888) 678-4327
    4246 Riverboat Rd.
    Ste. 300
    Salt Lake City, UT 84123